These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38503527)
41. Transplantation of megadoses of purified haploidentical stem cells. Handgretinger R; Schumm M; Lang P; Greil J; Reiter A; Bader P; Niethammer D; Klingebiel T Ann N Y Acad Sci; 1999 Apr; 872():351-61; discussion 361-2. PubMed ID: 10372137 [TBL] [Abstract][Full Text] [Related]
42. CD34+ enriched cell products intended for autologous transendocardial CD34+ cell transplantation release significant amounts of angiopoietin-1. Rozman JZ; Jez M; Malicev E; Krasna M; Vrtovec B; Cukjati M; Rozman P Transfus Clin Biol; 2019 Nov; 26(4):273-278. PubMed ID: 30709720 [TBL] [Abstract][Full Text] [Related]
43. CD34: to select or not to select? That is the question. Dao MA; Nolta JA Leukemia; 2000 May; 14(5):773-6. PubMed ID: 10803504 [TBL] [Abstract][Full Text] [Related]
44. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia. Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795 [TBL] [Abstract][Full Text] [Related]
45. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937 [TBL] [Abstract][Full Text] [Related]
46. Single-cell dissection of human hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation. Huo Y; Wu L; Pang A; Li Q; Hong F; Zhu C; Yang Z; Dai W; Zheng Y; Meng Q; Sun J; Ma S; Hu L; Zhu P; Dong F; Gao X; Jiang E; Hao S; Cheng T Sci Immunol; 2023 Mar; 8(81):eabn6429. PubMed ID: 36930730 [TBL] [Abstract][Full Text] [Related]
47. CD34+, kit+, rhodamine123(low) phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Ratajczak MZ; Pletcher CH; Marlicz W; Machalinski B; Moore J; Wasik M; Ratajczak J; Gewirtz AM Leukemia; 1998 Jun; 12(6):942-50. PubMed ID: 9639424 [TBL] [Abstract][Full Text] [Related]
48. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection. Sonoda Y J Autoimmun; 2008 May; 30(3):136-44. PubMed ID: 18243660 [TBL] [Abstract][Full Text] [Related]
49. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J Arthritis Rheum; 2002 Sep; 46(9):2301-9. PubMed ID: 12355477 [TBL] [Abstract][Full Text] [Related]
50. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells. Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422 [TBL] [Abstract][Full Text] [Related]
51. Determination of the relationship between CD34+ stem cell amount and DMSO in hematopoetic stem cell transplantation. Meriç N; Parmaksız A; Gülbaş Z Transpl Immunol; 2023 Jun; 78():101831. PubMed ID: 37019290 [TBL] [Abstract][Full Text] [Related]
52. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments. Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959 [TBL] [Abstract][Full Text] [Related]
57. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Handgretinger R; Lang P; Schumm M; Taylor G; Neu S; Koscielnak E; Niethammer D; Klingebiel T Bone Marrow Transplant; 1998 May; 21(10):987-93. PubMed ID: 9632271 [TBL] [Abstract][Full Text] [Related]
58. Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Rachamim N; Gan J; Segall H; Krauthgamer R; Marcus H; Berrebi A; Martelli M; Reisner Y Transplantation; 1998 May; 65(10):1386-93. PubMed ID: 9625023 [TBL] [Abstract][Full Text] [Related]
59. Peripheral blood stem cell harvesting and CD34-positive cell selection. Shpall EJ; Cagnoni PJ; Bearman SI; Ross M; Nieto Y; Jones RB Cancer Treat Res; 1997; 77():143-57. PubMed ID: 9071502 [No Abstract] [Full Text] [Related]
60. Coculture and transplant of purified CD34(+)Lin(-) and CD34(-)Lin(-) cells reveals functional interaction between repopulating hematopoietic stem cells. Hess DA; Karanu FN; Levac K; Gallacher L; Bhatia M Leukemia; 2003 Aug; 17(8):1613-25. PubMed ID: 12886251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]